← Back to all products
Retatrutide 10mg vial — research peptideFEATURED

Retatrutide

10mg/vial · Triple GIP/GLP-1/Glucagon Agonist

฿2,500฿2,400SALE
LINEWhatsApp
Purity >98%Keep RefrigeratedResearch Use Only

About this peptide

Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical trials demonstrated up to 24.2% mean body weight reduction at 48 weeks — the highest efficacy reported among investigational peptides.The glucagon receptor component adds direct hepatic fat oxidation, making it uniquely potent for metabolic research.

⚠️ For research use only.

Frequently Asked Questions

  • Retatrutide is a next-generation triple receptor agonist that activates GLP-1, GIP, and glucagon (GCG) pathways simultaneously. In Phase 2 clinical trials it produced average body-weight reductions of up to 24% over 48 weeks — the strongest efficacy reported for any peptide in this class. Lotus Labs supplies Retatrutide at >98% purity for laboratory research only.